Immunotherapy Integration Hub Leadership

The Immunotherapy Integration Hub (IIH) brings together teams of researchers and research staff committed to transforming the way pediatric cancers are treated by speeding up progress toward immunotherapies that can cure the disease without the long-term effects that diminish survivors’ quality of life.

IIH Leadership

Immunotherapy Coordinating Center Leadership

  • Julie Park, MD, medical director
  • Rebecca Gardner, MD, associate medical director and leukemia and lymphoma program lead
  • Navin Pinto, MD, solid tumor program lead
  • Nicholas Vitanza, MD, brain tumor program lead
  • Cristin Gordon-Maclean, director of the ICC
  • Leslie Elliott, manager of clinical trial management
  • Zahid Hossain, supervisor of regulatory affairs
  • Deepthi Nair, supervisor of clinical data management
  • Tracie Van Etten, manager of quality assurance

Therapeutics Innovation Core Leadership

  • Michael Jensen, MD, executive director
  • Rimas Orentas, PhD, director of scientific integration
  • Joshua Gustafson, PhD, manager of process innovation
  • Adam Johnson, PhD, manager of research and development
  • Karen Spratt, PhD, manager of pre-clinical development
  • Ashley Wilson, PhD, manager of immunotherapy correlative studies